While the clinical relevance of these findings in a population largely free from kidney disease remains uncertain, the reductions in albuminuria, blood pressure, and the favourable safety profile support further investigation of retatrutides potential kidney-protective effects in high-risk populations
At the same time, it encourages your pancreas to release insulin after you eat and reduce its glucagon production
Patient stratification probably matters more than any single drug choice, because the variable results likely conceal responder subgroups
Symptoms of GLP-1 induced gastroparesis often match other common GI disorders
Gitanjali Srivastava, MD, is co-director of Vanderbilt Weight Loss Clinics
Elevated liver enzymes in long-term use